GLP-1 Medicines and Binge Eating Disorder: The Honest Facts
Binge eating disorder (BED) is a real eating disorder, not a willpower problem. The FDA-approved medicine for BED is lisdexamfetamine (Vyvanse), which is not a GLP-1. GLP-1 medicines like semaglutide and liraglutide are being studied for BED because they may reduce appetite and reward-driven eating, but the evidence is small and emerging, and they are not approved for BED. Evidence-based therapy such as cognitive behavioral therapy is the main first-line help. A GLP-1 should not be used for binge eating without eating-disorder screening and a specialist, because misuse can cause serious harm.
Unlock the complete article
Register with just your mobile number and OTP. No password and no payment.